References
Mygind N, Lund V. Intranasal corticosteroids for nasal polyposis: biological rationale, efficacy and safety. Treat Respir Med 2006; 5: 93–103
Radenne F, Lamblin C, Vandezande L-M, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999; 103: 79–84
Settipane GA. Nasal polyps: pathology, immunology and treatment. Am J Rhinol 1987; 1: 119–26
Settipane GA, Lund VJ, Bernstein JM, et al., editors. Nasal polyps: epidemiology, pathogenesis and treatment. Providence (RI): TheNew England and Regional Allergy Proceedings, 1997
Larsen K, Tos M. Clinical course of patients with primary nasal polyps. Acta Otolaryngol (Stockh) 1994; 114: 556–9
Vento SI, Ertama LO, Hytönen ML, et al. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000; 85: 209–14
Larsen K. The clinical relationship of nasal polyps to asthma. In: Settipane G, Lund VJ, Bernstein JM, et al., editors. Nasal polyps: epidemiology, pathogenesis and treatment. Providence (RI): Oceanside Publications, 1997: 97–104
Mygind N, Pedersen CB, Prytz S, et al. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975; 5: 159–64
Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977; 15: 17–23
Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 2000; 38: 63–5
Tos M, Svendstrup F, Arndal H, et al. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinol 1998; 12: 183–9
Vendelo Johansen L, Ilium P, Kristensen S, et al. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol Allied Sci 1993; 18: 524–7
Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci 1995; 20: 26–30
Holopainen E, Grahne B, Malmberg H, et al. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl 1982; 122: 221–8
Penttilä M, Poulsen P, Hollingworth K, et al. Dose-related efficacy and tolerability of fluticasone proprionate nasal drops 400 μg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 2000; 30: 94–102
Keith P, Nieminen J, Hollingworth K, et al. Efficacy and tolerability of fluticasone proprionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000; 30: 1460–8
Lund VJ, Flood J, Sykes AP, et al. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998; 124: 513–8
Holmberg K, Juliusson S, Balder B, et al. Fluticasone proprionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 1997; 78: 270–6
Rinne J, Simola M, Malmberg H, et al. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome. J Allergy Clin Immunol 2002; 109: 426–32
Pedersen CB, Mygind N, Sørensen H, et al. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. Acta Otolaryngol (Stockh) 1976; 82: 256–9
Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982; 20: 144–8
Virolainen E, Puhakka H. The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 1980; 18: 9–18
Hartwig S, Linden M, Laurent C, et al. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). J Laryngol Otol 1988; 102: 148–51
Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982; 20: 149–58
Dingsör G, Kramer J, Olsholt R, et al. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy: a randomized double-blind parallel, placebo-controlled study. Rhinology 1985; 23: 49–58
Rowe-Jones JM, Medcalf M, Durham SR, et al. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005; 43: 2–10
Dijkstra MD, Ebbens F, Poublon R, et al. Fluticasone proprionate does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps one year after functional endoscopic sinus surgery. J Allergy Clin Immunol 2004; 34: 1395–400
Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000; 105: E23
Blomqvist EH, Lundblad L, Änggård A, et al. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001; 107: 224–8
Rights and permissions
About this article
Cite this article
Intranasal corticosteroids are the mainstay of treatment for nasal polyposis. Drugs Ther. Perspect 22, 11–14 (2006). https://doi.org/10.2165/00042310-200622120-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200622120-00004